Medtronic (NYSE:MDT) is the most likely rival to Intuitive Surgical‘s (NSDQ:ISRG) dominance in the robot-assisted surgery space, but is still at least a year away from putting a competing device on the market, according to 1 analyst covering the medical device industry. Sunnyvale, Calif.-based Intuitive has a long lead, having had its flagship da Vinci system since 2000 and is […]
Medtronic
Medtronic’s Navigate lung trial enrolls 1st European patient
Medtronic (NYSE:MDT) said today that it enrolled the 1st European patient in a huge, real-world study of the SuperDimension lung device it acquired along with Covidien early last year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm post-market study […]
Report: Medtronic scales back at former Covidien HQ in Mass.
Medtronic (NYSE:MDT) is scaling back in Mansfield, Mass., as it looks to cut costs at the former headquarters of its Covidien subsidiary.* Medtronic spokesman Fernando Vivanco told MassDevice.com today that Medtronic is consolidating from 4 to 3 buildings it leases in Mansfield, about an hour south of Boston. The move is part of a conversion to a “flexible workspace” that allows […]
Bill Hawkins on his time at Medtronic, Immucor and 25 years in the hot seat | DeviceTalks podcast
For nearly a quarter of a century, William “Bill” Hawkins sat in the corner office of medtech companies of all sizes, before stepping down from Immucor last year to become the Atlanta-based company’s lead director. Hawkins is best known for his 4 years as CEO of Medtronic, where he served in the corner office from […]
Medtronic launches real-world trial for CoreValve Evolut R heart valve
Medtronic (NYSE:MDT) said today that it’s launching a real-world trial of its CoreValve Evolut R transcatheter aortic valve implant in high- and extreme-risk patients. The 1,000-patient Evolut R Forward trial is a single-arm, prospective study with a primary endpoint of all-cause mortality at 30 days, with secondary endpoints of Valve Academic Research Consortium-2 safety and efficacy. The study is designed for […]
FDA approves Medtronic’s Specify SureScan MRI-safe neurostim leads
Medtronic (NYSE:MDT) said today that the FDA approved its MRI-safe Specify SureScan spinal cord stimulation leads for treating chronic pain. The Fridley, Minn.-based medtech titan said the approval means it is the sole company to offer a full U.S. suite of SCS devices that are safe for full-body MRI scans. The Specify SureScan leads are due to […]
Medtronic sees rev grow, beats street in Q3 on lifted US sales
Medtronic (NYSE:MDT) today reported a solid 3rd quarter for 2016, seeing revenue rise over 60% compared against last year, though shares have dipped in early morning trading. Fridley, Minn.-based Medtronic reported profits of $1.1 billion, or 77¢ per share, on sales of $6.9 billion for the 3 months ended January 29. That amounts to a 12.1% […]
RIP medical device pioneer Alfred Mann | Personnel Moves
Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded. Mann founded 17 companies over his 70-year career, in industries ranging from aerospace to medtech, according to the L.A. Times. After Johns Hopkins University researchers in 1969 […]
Medtronic claims title to world’s 1st app-based remote monitoring for pacemakers
Medtronic (NYSE:MDT) said today that its Canadian subsidiary won approval there for the world’s 1st app-based remote monitor for pacemakers, the MyCareLink Smart system. The Health Canada nod allows patients with compatible Medtronic pacers to use a smartphone or tablet to send data to caregivers, using a handheld portable device reader and the MyCareLink Smart app, the Fridley, Minn.-based […]
Medtronic wins CE Mark for line of MR-safe CRT-Ds
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for its full line of magnetic resonance imaging safe cardiac resynchronization therapy defibrillators, now approved for use with 3 Tesla MRI machines. The approval includes Fridley, Minn.-based Medtronic’s Claria MRI quad CRT-D SureScan, Amplia MRI quad CRT-D and Compia MRI quad systems, which […]
FDA approves trial for low-risk patients with MDT’s CoreValve Evolut R
Medtronic (NYSE:MDT) said today that the FDA granted an investigational device exemption for a clinical trial of its CoreValve Evolut R implantable heart valve in patients at low risk for adverse events from traditional heart valve replacement surgery. The expanded indication means a likely spring debut for the 1,200-patient trial in patients with severe aortic stenosis with a […]